Back

Administration of a soluble ADPase, AZD3366, on top of ticagrelor confers additional cardioprotective benefits to that of ticagrelor alone

29 August 2020 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Thrombosis, Bleeding / Platelets Platelets, Haemostasis, Coagulation ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Gemma Vilahur

Hospital de la Santa Creu i Sant Pau, Barcelona (Spain)

6 More presentations in this session

Presentation thumbnail
Distinct dietary alpha-linolenic acid-dependent shifts in the fecal microbiome composition suppresses aging-associated inflammatory responses and thrombus formation
Doctor S. Saeedi (Schlieren, CH)
Abstract Slides
Presentation thumbnail
Next Generation Sequencing reveals profound transcriptomic differences between reticulated and non-reticulated platelets from healthy donors, CCS- and STEMI patients
Professor D. Trenk (Bad Krozingen, DE)
Abstract Slides
Presentation thumbnail
Repeated social defeat exaggerates fibrin-rich clot formation in FeCl3-induced arterial thrombosis mouse model by enhancing NETs formation via modulation of neutrophil functional properties
Doctor T. sugimoto (Kyoto, JP)
Abstract Slides
Presentation thumbnail
Role of toll-like receptor 4 on tissue factor regulation in human monocytes
Doctor V. Scalise (Pisa, IT)
Abstract Slides
Presentation thumbnail
Clot formation, lysis and ultrastructure in patients with acute phase myocardial infarction
Doctor A. Siniarski (Krakow, PL)
Abstract Slides

Access the full session

Session thumbnail
Thrombosis, Bleeding / Platelets

The Event

Event poster

ESC Congress 2020

29 August - 1 September 2020

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources